Literature DB >> 11229647

Changes of serum prostate-specific antigen following high energy thick loop prostatectomy.

R F Talic1, A M El-Tiraifi, S Altaf, T B Hargreave.   

Abstract

We evaluated the effect of the high electrocuting energy used with the thick loop, in transurethral vaporization resection of the prostate (TUVRP), on serum prostate-specific antigen (PSA). Forty-eight patients with benign protatic hyperplasia (BPH) were included in this prospective single arm sequential study. All patients had TUVRP using the 'Wing' thick resection electrode (Richard Wolf, Germany). Serum PSA was measured before, 1 day and 6 weeks in the morning post TUVRP. PSA values were correlated to preoperative prostate size and to prostatic resection weight. Serum PSA values (mean +/- SD) were 6.29+/-4.4 ng/ml, 14.9+/-11.1 and 2.3+/-1.9 before, 1 day and 6 weeks post TUVRP respectively. The mean increase in the PSA at 1 day over baseline value was 2.72, this was statistically significant (p < or = 0.0001). The PSA level returned to less than pre TUVRP value in all but 3 patients by 6 weeks. The PSA value 1 day post TUVRP correlated well with the pre PSA level, prostate size and prostatic resection weight (r = 0.58, r = 0.38 and r = 0.44 respectively) however, the PSA level at 6 weeks correlated only to pre TUVRP values (r = 0.53). We conclude that that serum PSA is not reliable within 6 weeks of TUVRP. The reversible increase in serum PSA value is similar to other forms of prostatectomy which, suggests that the increased level of electrosurgical energy that is used in TUVRP does not have an added adverse effect on the PSA levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11229647     DOI: 10.1023/a:1007170029017

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  14 in total

1.  Prostate-specific antigen. Improving its ability to diagnose early prostate cancer.

Authors:  J E Oesterling
Journal:  JAMA       Date:  1992 Apr 22-29       Impact factor: 56.272

2.  Effect of transurethral electrovaporization of the prostate on serum prostate specific antigen concentration.

Authors:  S Küpeli; T Soygür; E Yilmaz; S Aytaç
Journal:  BJU Int       Date:  1999-05       Impact factor: 5.588

3.  Effect of laser prostatectomy on the serum prostate-specific antigen concentration: results of a prospective study.

Authors:  A Koşar; K Sarica; E Ozdíler; M Budak; C Dínçel; O Gögüş
Journal:  Eur Urol       Date:  1998-09       Impact factor: 20.096

Review 4.  Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

Authors:  T J Polascik; J E Oesterling; A W Partin
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

5.  The "Wedge" resection device for electrosurgical transurethral prostatectomy.

Authors:  A P Perlmutter; D A Schulsinger
Journal:  J Endourol       Date:  1998-02       Impact factor: 2.942

Review 6.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

Authors:  J E Oesterling
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

7.  Transurethral electrovaporization-resection of the prostate using the "wing" cutting electrode: preliminary results of safety and efficacy in the treatment of men with prostatic outflow obstruction.

Authors:  R F Talic
Journal:  Urology       Date:  1999-01       Impact factor: 2.649

8.  Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels.

Authors:  J J Yuan; D E Coplen; J A Petros; R S Figenshau; T L Ratliff; D S Smith; W J Catalona
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

9.  Influence of digital examination, cystoscopy, transrectal ultrasonography and needle biopsy on the concentration of prostate-specific antigen.

Authors:  C Deliveliotis; G Alivizatos; N J Stavropoulos; K Makrychoritis; G Koutsokalis; Z Kiriakakis; A Kostakopoulos; C Dimopoulos
Journal:  Urol Int       Date:  1994       Impact factor: 2.089

10.  Reference range of prostate-specific antigen after transurethral resection of the prostate.

Authors:  G Aus; S Bergdahl; R Frösing; P Lodding; E Pileblad; J Hugosson
Journal:  Urology       Date:  1996-04       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.